Evaluation of a system using oral mucosal transudate for HIV-1 antibody screening and confirmatory testing

JAMA

Volumn 277, Issue 3, 1997, Pages 254-258

  Gallo, Dana ^a   George, J Richard ^b   Fitchen, John H ^b   Goldstein, Andrew S ^b   Hindahl, Michael S ^b  

^a VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^b Epitope Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CONTROLLED STUDY; ELECTROIMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; MALE; MOUTH MUCOSA; PRIORITY JOURNAL; SALIVA ANALYSIS;

EID: 0031022207     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.3.254     Document Type: Article

References (33)

1. Archibald DW, Zon L, Groopman JE, McLane MF, Essex M. Antibodies to human T-lymphotropic virus type III (HTLV-III) in saliva of acquired immunodeficiency syndrome (AIDS) patients and in persons at risk for AIDS. Blood. 1986;67:831-834.
2. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet. 1987;2:72-75.
3. Johnson AM, Parry JV, Best SJ, Smith AM, de Silva M, Mortimer PP. HIV surveillance by testing saliva. AIDS. 1988;2:369-371.
4. Holmström P, Syrjänen S, Laine P, Valle S-L, Suni J. HIV antibodies in whole saliva detected by ELISA and Western blot assays. J Med Virol. 1990; 30:245-248.
5. Crofts N, Nicholson S, Coghlan P, Gust ID. Testing of saliva for antibodies to HIV-1. AIDS. 1991; 5:561-563.
6. Major CJ, Read SE, Coates RA, et al. Comparison of saliva and blood for human immunodeficiency virus prevalence testing. J Infect Dis. 1991; 163:699-702.
7. Behets FM, Edidi B, Quinn TC, et al. Detection of salivary HIV-1-specific IgG antibodies in high-risk populations in Zaire. J Acquir Immune Defic Syndr. 1991;4:183-187.
8. van den Akker R, van den Hoek JAR, van den Akker WMR, et al. Detection of HIV antibodies in saliva as a tool for epidemiological studies. AIDS. 1992;6:953-957.
9. Frerichs RR, Htoon MT, Eskes N, Lwin S. Comparison of saliva and serum for HIV surveillance in developing countries. Lancet. 1992;340:1496-1499.
10. King A, Marion SA, Cook D, et al. Accuracy of a saliva test for HIV antibody. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:172-175.
11. Malamud D, Friedman HM. HIV in the oral cavity: virus, viral inhibitory activity, and antiviral antibodies. Crit Rev Oral Biol Med. 1993;4:461-466.
12. Yeung SCH, Kazazi F, Randle CGM, et al. Patients infected with human immunodeficiency virus type 1 have low levels of virus in saliva even in the presence of periodontal disease. J Infect Dis. 1993; 167:803-809.
13. Coates R, Millson M, Myers T, et al. The benefits of HIV antibody testing of saliva in field research. Can J Public Health. 1991;82:397-398.
14. Söderling E. Practical aspects of salivary analysis. In: Tenovuo JO, ed. Human Saliva: Clinical Chemistry and Microbiology. Boca Raton, Fla: CRC Press; 1989;1:1-24.
15. Mortimer PP, Parry JV. Detection of antibody to HIV in saliva: a brief review. Clin Diagn Virol. 1994;2:231-243.
16. Brandtzaeg P. Salivary immunoglobulins. In: Tenovuo JO, ed. Human Saliva: Clinical Chemistry and Microbiology. Boca Raton, Fla: CRC Press; 1989:2:1-54.
17. Cordeiro ML, Turpin CS, McAdams SA. A comparative study of saliva and OraSure® oral fluid. Ann N Y Acad Sci. 1993;694:330-331.
18. Centers for Disease Control and Prevention. Model Performance Evaluation Program: HIV-1 Testing Report. Atlanta, Ga: Centers for Disease Control and Prevention; 1995.
19. Vecchio TJ. Predictive value of a single diagnostic test in selected populations. N Engl J Med. 1966;274:1171-1173.
20. Soto-Ramírez LE, Hernández-Gómez L, Sifuentes-Osornio J, et al. Detection of specific antibodies in gingival crevicular transudate by enzyme-linked immunosorbent assay for diagnosis of human immunodeficiency virus type 1 infection. J Clin Microbiol. 1992;30:2780-2783.
21. Emmons WW, Paparello SF, Decker CF, Sheffield JM, Lowe-Bey FH. A modified ELISA and Western blot accurately determine antihuman immunodeficiency virus type 1 antibodies in oral fluids obtained with a special collecting device. J Infect Dis. 1995;171:1406-1410.
22. Gaudette D, North L, Hindahl M, Griffin K, Klimkow N, Thieme T. Stability of clinically significant antibodies in saliva and oral fluid. J Clin Immunoassay. 1994;17:171-175.
23. OraSure HIV-1 Oral Specimen Collection Device: Package Insert. Beaverton, Ore: Epitope Inc; 1994.
24. Bagg J, Perry KR, Parry JV, Mortimer PP, Peters TJ. The influence of dental status on the detection of IgG class anti-viral antibodies in human saliva. Arch Oral Biol. 1991;36:221-226.
25. Gerberding J. Is antiretroviral treatment after percutaneous HIV exposure justified? Ann Intern Med. 1993;118:979-980.
26. Marcus R, CDC Cooperative Needlestick Surveillance Group. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus. N Engl J Med. 1988;319:1118-1123.
27. Feinberg J, Lee J, Kelly E, Strongin W. Utility of a home test kit for the diagnosis of HIV infection. In: Proceedings of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); September 17-20, 1995:247; San Francisco, Calif. Abstract 1232.
28. Doll LS, Kennedy MB. HIV counseling and testing: what is it and how well does it work? In: Schochetman G, George JR, eds. AIDS Testing. 2nd ed. New York, NY: Springer-Verlag; 1994:302-319.
29. Centers for Disease Control and Prevention. Publicly funded HIV counseling and testing-United States, 1991. MMWR Morb Mortal Wkly Rep. 1992;41:613-617.
30. Centers for Disease Control. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509-515.
31. Connor EM, Sperling RS, Gelber R, et al, the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med. 1994; 331:1173-1180.
32. Danner SA, Carr A, Leonard JM, et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. N Engl J Med. 1995;333:1528-1533.
33. Mathez D, De Truchis P, Gorin I, et al. Ritonavir, AZT, DDC, as a triple combination in AIDS patients. Presented at the 3rd Conference on Retroviruses and Opportunistic Infections; January 28-February 1, 1996:106; Washington, DC. Abstract 285.